These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 21873682)
1. Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration. Huang H; Van de Veire S; Dalal M; Parlier R; Semba RD; Carmeliet P; Vinores SA Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7565-73. PubMed ID: 21873682 [TBL] [Abstract][Full Text] [Related]
2. Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy in the rat 50/10 model. Trichonas G; Lee TJ; Hoppe G; Au J; Sears JE Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4919-26. PubMed ID: 23761085 [TBL] [Abstract][Full Text] [Related]
3. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470 [TBL] [Abstract][Full Text] [Related]
4. Aldose reductase deficiency reduced vascular changes in neonatal mouse retina in oxygen-induced retinopathy. Fu ZJ; Li SY; Kociok N; Wong D; Chung SK; Lo AC Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5698-712. PubMed ID: 22836764 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of VEGF by retinoic acid during hyperoxia prevents retinal neovascularization and retinopathy. Wang L; Shi P; Xu Z; Li J; Xie Y; Mitton K; Drenser K; Yan Q Invest Ophthalmol Vis Sci; 2014 May; 55(7):4276-87. PubMed ID: 24867581 [TBL] [Abstract][Full Text] [Related]
6. Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy. Sears JE; Hoppe G; Ebrahem Q; Anand-Apte B Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19898-903. PubMed ID: 19057008 [TBL] [Abstract][Full Text] [Related]
7. Epithelial Membrane Protein 2 (EMP2) Promotes VEGF-Induced Pathological Neovascularization in Murine Oxygen-Induced Retinopathy. Sun M; Wadehra M; Casero D; Lin MC; Aguirre B; Parikh S; Matynia A; Gordon L; Chu A Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):3. PubMed ID: 32031575 [TBL] [Abstract][Full Text] [Related]
8. Effects and Mechanism of Action of PX-478 in Oxygen-Induced Retinopathy in Mice. Pan X; Lv Y Ophthalmic Res; 2020; 63(2):182-193. PubMed ID: 31955159 [TBL] [Abstract][Full Text] [Related]
9. TMP prevents retinal neovascularization and imparts neuroprotection in an oxygen-induced retinopathy model. Liang X; Zhou H; Ding Y; Li J; Yang C; Luo Y; Li S; Sun G; Liao X; Min W Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2157-69. PubMed ID: 22410554 [TBL] [Abstract][Full Text] [Related]
10. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Pierce EA; Foley ED; Smith LE Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081 [TBL] [Abstract][Full Text] [Related]
11. Molecular hydrogen promotes retinal vascular regeneration and attenuates neovascularization and neuroglial dysfunction in oxygen-induced retinopathy mice. Guo Y; Qin J; Sun R; Hao P; Jiang Z; Wang Y; Gao Z; Zhang H; Xie K; Zhang W Biol Res; 2024 Jun; 57(1):43. PubMed ID: 38915069 [TBL] [Abstract][Full Text] [Related]
12. Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p/HIF-1α/VEGF pathway. Zhao K; Jiang Y; Zhang J; Shi J; Zheng P; Yang C; Chen Y Cell Cycle; 2022 Oct; 21(19):2091-2108. PubMed ID: 35695424 [TBL] [Abstract][Full Text] [Related]
13. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha. Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324 [TBL] [Abstract][Full Text] [Related]
14. Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model. Saito Y; Uppal A; Byfield G; Budd S; Hartnett ME Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1591-8. PubMed ID: 18385079 [TBL] [Abstract][Full Text] [Related]
15. Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia. Rishi MT; Selvaraju V; Thirunavukkarasu M; Shaikh IA; Takeda K; Fong GH; Palesty JA; Sanchez JA; Maulik N Microvasc Res; 2015 Jan; 97():181-8. PubMed ID: 25446011 [TBL] [Abstract][Full Text] [Related]
16. Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP. Miyamoto N; Mandai M; Takagi H; Suzuma I; Suzuma K; Koyama S; Otani A; Oh H; Honda Y Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2007-14. PubMed ID: 12037012 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Gardiner TA; Gibson DS; de Gooyer TE; de la Cruz VF; McDonald DM; Stitt AW Am J Pathol; 2005 Feb; 166(2):637-44. PubMed ID: 15681845 [TBL] [Abstract][Full Text] [Related]
18. Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model. Zhang W; Yokota H; Xu Z; Narayanan SP; Yancey L; Yoshida A; Marcus DM; Caldwell RW; Caldwell RB; Brooks SE Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6384-95. PubMed ID: 21705685 [TBL] [Abstract][Full Text] [Related]
19. Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy. Abdelsaid MA; Pillai BA; Matragoon S; Prakash R; Al-Shabrawey M; El-Remessy AB J Pharmacol Exp Ther; 2010 Jan; 332(1):125-34. PubMed ID: 19815813 [TBL] [Abstract][Full Text] [Related]
20. Diacylglycerol kinase (DGK) inhibitor II (R59949) could suppress retinal neovascularization and protect retinal astrocytes in an oxygen-induced retinopathy model. Yang L; Xu Y; Li W; Yang B; Yu S; Zhou H; Yang C; Xu F; Wang J; Gao Y; Huang Y; Lu L; Liang X J Mol Neurosci; 2015 May; 56(1):78-88. PubMed ID: 25451596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]